Intravesical Evans Strain BCG Therapy: Quantitative Immunohistochemical Analysis of the Immune Response within the Bladder Wall-Reference-Cited by-同舟云学术

Intravesical Evans Strain BCG Therapy: Quantitative Immunohistochemical Analysis of the Immune Response within the Bladder Wall

Published:1992-06 Issue:6 Volume:147 Page:1636-1642
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Prescott S.¹,James K.¹,Hargreave T.B.¹,Chisholm G.D.¹,Smyth J.F.¹

Affiliation:

1. From the University Department of Surgery/Urology And Imperial Cancer Research Fund Medical Oncology Unit, Edinburgh, Scotland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Lamm, D. L.: BCG immunotherapy in bladder cancer. In: 1987 Urology Annual. Appleton and Lange, Norwalk, Connecticut/Los Altos, California, pp. 67-86, 1987.

2. Bacillus Calmette-Guérin alters the progression of superficial bladder cancer;Herr;J. Clin. Oncol.,1988

3. BCG and cancer (2 parts);Bast;N. Eng. J. Med.,1974

4. Bacillus Calmette Guerin as an anti-tumour agent. The interaction with cells of the mammalian immune system;Davies;Biochim. Biophys. Acta.,1982

5. Expression of MHC Class II antigen in human B cell leukaemia and non-Hodgkins lymphoma;Guy;Br. J. Cancer,1986

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the safety and immunological effects of Bacillus Calmette–Guérin in combination with checkpoint inhibitor therapy in a patient with neuroendocrine carcinoma: a case report;Journal of Medical Case Reports;2023-09-04

2. Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer;Cells;2023-07-26

3. Autoimmune disorders caused by intravesical bacillus Calmette-Guerine treatment: A systematic review;Autoimmunity Reviews;2023-06

4. Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition;Frontiers in Immunology;2022-10-11

5. A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology;Pilot and Feasibility Studies;2022-09-03